Health Care & Life Sciences » Pharmaceuticals | BLIS Technologies Ltd.

BLIS Technologies Ltd. | Cash Flow

Fiscal year is April-March. All values NZD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,541.00
1,373.00
816.00
24.00
1,042.00
381
Depreciation, Depletion & Amortization
493.00
560.00
557.00
609.00
611.00
525
Other Funds
23.00
10.00
93.00
61.00
30.00
9
Funds from Operations
1,025.00
823.00
166.00
646.00
461.00
897
Changes in Working Capital
49.00
272.00
345.00
402.00
579.00
1,480
Net Operating Cash Flow
976.00
1,095.00
511.00
244.00
118.00
583
Capital Expenditures
350.00
426.00
408.00
315.00
476.00
Sale of Fixed Assets & Businesses
2.00
5.00
-
-
-
Net Investing Cash Flow
348.00
421.00
408.00
315.00
476.00
Issuance/Reduction of Debt, Net
-
-
-
-
290.00
Net Financing Cash Flow
4,227.00
-
-
-
322.00
Net Change in Cash
2,903.00
1,506.00
937.00
69.00
6.00
Free Cash Flow
1,226.00
1,438.00
831.00
108.00
237.00
Change in Capital Stock
4,227.00
-
-
-
32.00
Exchange Rate Effect
-
10.00
18.00
2.00
30.00

About BLIS Technologies

View Profile
Address
81 Glasgow Street
Dunedin OT 9012
New Zealand
Employees -
Website http://www.blis.co.nz
Updated 07/08/2019
BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. It operates in the following geographical areas: Australasia, Asia (including China), Europe, and North America. The company was founded in June 2000 and is headquartered in Dunedin, New Zealand.